We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNFT
551
DELISTED
Benefitfocus, Inc.
BNFT
| $1.12M | 0.02% |
28,145
| – | – |
|
|
INWK
552
DELISTED
InnerWorkings, Inc.
INWK
| $1.12M | 0.02% |
119,305
+98,605
| +476% | +$861K |
|
553
PVH
PVH
$3.71B
| $1.12M | 0.02% |
10,150
+750
| +8% | +$77.5K |
|
554
DaVita
DVA
$15.1B
| $1.12M | 0.02% |
+16,910
| New | +$1.19M |
|
555
Ingredion
INGR
$6.38B
| $1.11M | 0.02% |
8,350
-980
| -11% | -$131K |
|
|
CSII
556
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.11M | 0.02% |
+46,808
| New | +$1.02M |
|
557
Powell Industries
POWL
$8.46B
| $1.11M | 0.02% |
82,920
+28,830
| +53% | +$368K |
|
|
WRI
558
DELISTED
Weingarten Realty Investors
WRI
| $1.1M | 0.02% |
28,220
| – | – |
|
|
RRTS
559
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $1.1M | 0.02% |
5,514
-424
| -7% | -$86.1K |
|
560
Boston Beer
SAM
$1.88B
| $1.1M | 0.02% |
+7,070
| New | +$1.23M |
|
561
AGCO
AGCO
$8.78B
| $1.09M | 0.02% |
22,190
-24,320
| -52% | -$1.17M |
|
|
SAGE
562
DELISTED
Sage Therapeutics
SAGE
| $1.08M | 0.02% |
23,560
-35,110
| -60% | -$1.43M |
|
|
BWLD
563
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.08M | 0.02% |
+7,660
| New | +$1.19M |
|
564
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.07M | 0.02% |
8,850
-15,507
| -64% | -$2.09M |
|
565
Provident Financial Services
PFS
$3.11B
| $1.07M | 0.02% |
50,369
| – | – |
|
|
EXTN
566
DELISTED
Exterran Corporation
EXTN
| $1.07M | 0.02% |
68,058
-30,712
| -31% | -$425K |
|
567
BorgWarner
BWA
$13.2B
| $1.07M | 0.02% |
34,428
-126,607
| -79% | -$3.73M |
|
568
JPMorgan Chase
JPM
$939B
| $1.06M | 0.02% |
15,920
+640
| +4% | +$41.7K |
|
|
PETX
569
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.06M | 0.02% |
+113,300
| New | +$941K |
|
|
BEAV
570
DELISTED
B/E Aerospace Inc
BEAV
| $1.05M | 0.02% |
20,420
-1,800
| -8% | -$87K |
|
|
EVDY
571
DELISTED
Everyday Health, Inc.
EVDY
| $1.05M | 0.02% |
136,952
-5,200
| -4% | -$40.7K |
|
572
Helix Energy Solutions
HLX
$1.46B
| $1.05M | 0.02% |
128,951
-502,516
| -80% | -$3.8M |
|
573
Genpact
G
$5.3B
| $1.04M | 0.02% |
+43,300
| New | +$1.07M |
|
|
XCRA
574
DELISTED
Xcerra Corporation
XCRA
| $1.03M | 0.02% |
169,629
-5,100
| -3% | -$30K |
|
575
Biglari Holdings Class B
BH
$1.2B
| $1.02M | 0.02% |
3,522
+2,008
| +133% | +$573K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.